These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24860650)

  • 21. Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C
    Rousselière A; Gérard N; Delbos L; Guérif P; Giral M; Bressollette-Bodin C; Charreau B
    Front Immunol; 2022; 13():1063690. PubMed ID: 36532017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
    Cho HI; Han H; Kim CC; Kim TG
    J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytomegalovirus infection and the immune response to exercise.
    Simpson RJ; Bigley AB; Spielmann G; LaVoy EC; Kunz H; Bollard CM
    Exerc Immunol Rev; 2016; 22():8-27. PubMed ID: 26853134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells.
    Jackson SE; Sedikides GX; Okecha G; Poole EL; Sinclair JH; Wills MR
    Front Immunol; 2017; 8():733. PubMed ID: 28694811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
    Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
    J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMV-Specific Immune Response-New Patients, New Insight: Central Role of Specific IgG during Infancy and Long-Lasting Immune Deficiency after Allogenic Stem Cell Transplantation.
    Zdziarski P
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry.
    Rousselière A; Delbos L; Bressollette C; Berthaume M; Charreau B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
    Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
    Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuning the Orchestra: HCMV vs. Innate Immunity.
    Dell'Oste V; Biolatti M; Galitska G; Griffante G; Gugliesi F; Pasquero S; Zingoni A; Cerboni C; De Andrea M
    Front Microbiol; 2020; 11():661. PubMed ID: 32351486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
    Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
    Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.
    Provenzano M; Sais G; Bracci L; Egli A; Anselmi M; Viehl CT; Schaub S; Hirsch HH; Stroncek DF; Marincola FM; Spagnoli GC
    J Cell Mol Med; 2009 Aug; 13(8B):2131-2147. PubMed ID: 19604317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population.
    Di Bona D; Accardi G; Aiello A; Bilancia M; Candore G; Colomba C; Caruso C; Duro G; Gambino CM; Macchia L; Pandey JP
    Immunology; 2018 Apr; 153(4):523-531. PubMed ID: 29067686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation.
    Gerna G; Lilleri D; Fornara C; Comolli G; Lozza L; Campana C; Pellegrini C; Meloni F; Rampino T
    Am J Transplant; 2006 Oct; 6(10):2356-64. PubMed ID: 16889599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive immunotherapy of HCMV infection.
    Kapp M; Tan SM; Einsele H; Grigoleit G
    Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles Vaccination.
    Cox M; Adetifa JU; Noho-Konteh F; Njie-Jobe J; Sanyang LC; Drammeh A; Plebanski M; Whittle HC; Rowland-Jones SL; Robertson I; Flanagan KL
    Front Immunol; 2020; 11():1083. PubMed ID: 32582177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.